Investment analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Get Rating) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.
Retractable Technologies Stock Down 4.7 %
RVP stock opened at $1.22 on Wednesday. The business has a 50-day moving average of $1.63 and a 200-day moving average of $1.85. Retractable Technologies has a fifty-two week low of $1.20 and a fifty-two week high of $5.17. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.60 and a quick ratio of 6.46. The stock has a market capitalization of $36.53 million, a P/E ratio of -24.40 and a beta of 2.15.
Retractable Technologies (NYSE:RVP – Get Rating) last announced its earnings results on Thursday, March 30th. The company reported ($0.13) earnings per share for the quarter. Retractable Technologies had a positive return on equity of 1.39% and a negative net margin of 2.63%. The firm had revenue of $12.68 million for the quarter.
Institutional Inflows and Outflows
Retractable Technologies Company Profile
Retractable Technologies, Inc engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.
Further Reading
- Get a free copy of the StockNews.com research report on Retractable Technologies (RVP)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.